Good news | Xingyue Biotechnology has won the "Innovation Strategy Source Excellent Achievement Award" in Yuhang District, and is bravely exploring new quality productivity with silk technology
On the afternoon of February 18th, the "Climbing the Peak towards the Future" Yuhang District Economic High quality Development Conference was grandly held at Hangzhou Future Science and Technology City. The conference solemnly commended 63 outstanding enterprises (units) that have made outstanding contributions to the economic development of Yuhang District in 2024. Among them, Xingyue Biotechnology won the "Yuhang District Innovation Strategy Source Excellent Achievement Award" for its breakthrough innovation achievements in the field of medical silk materials. Zhao Hongshi, the company's general manager, was invited to attend and receive the award on stage.
This conference focuses on five major themes: talent leadership, innovation driven, industrial prosperity, gradient cultivation, and factor guarantee. It brings together representatives from various sectors such as government, universities, research institutes, and enterprises to witness the remarkable achievements of Yuhang District in economic development, technological innovation, and digital economy.
At the same time, the conference released the "Several Policy Opinions on Accelerating the Formation of New Quality Productivity and Promoting High Quality Economic Development in Yuhang District". With the support of a new round of industrial policies, Xingyue Biotechnology will deepen its research and innovation in the field of medical silk biomaterials with a stronger posture and firm confidence, actively respond to the "Golden 68" new policies after iteration and upgrading, deeply participate in scientific and technological innovation projects and talent projects, resonate with the pulse of economic development in Yuhang District, accelerate the construction of a "medical+consumption" dual wheel driven industrial ecology, and start a new round of technological breakthroughs in medical silk materials.
Xingyue Biotechnology has won the first honor at the beginning of 2025 with its leading silk fibroin technology, once again establishing its benchmark position in the field of biomedical materials. As a leading enterprise deeply engaged in silk fibroin research and industrialization for 20 years, its innovative achievements have deeply reconstructed the development pattern of three major fields: sports medicine and regenerative medicine, medical beauty, and efficacy skincare. The independently developed third type medical device "silk fibroin membrane dressing" and the officially entered clinical trial third type implanted device "silk fibroin hernia repair patch" further promote the revolutionary leap of medical silk materials from laboratory to clinical application in China. At present, the enterprise has built a matrix of more than 20 invention patents, forming a full industry chain protection system covering trauma repair, tissue regeneration, high-end medical beauty, and biological skincare. From pioneering the discovery of the medical value of silk to establishing a full industry chain platform for medical silk fibroin protein, Xingyue Biotechnology is reshaping the innovation landscape of medical silk materials with Chinese intelligent manufacturing.
The vigorous growth of Xingyue Biotechnology is a microcosm of Yuhang District's efforts to create a "source of technological innovation". In the future, under the escort of economic policies in Yuhang District, Xingyue Biotechnology will continue to innovate with the resilience of "one thread", work together with universities and industry chain partners to overcome the "bottleneck" problem of biomaterials, provide better "Chinese solutions" for global patients and consumers, and take big steps towards the grand goal of internationalization of the biopharmaceutical industry.
